Drug Search Results

Sevacizumab

Alternative Names: sevacizumab
Latest Update: 2024-05-15
Latest Update Note: PubMed Publication

Product Description

Humanized Anti-VEGF Monoclonal Antibody for Platinum-Resistant Recurrent Ovarian Cancer (Sourced from: https://clinicaltrials.gov/ct2/show/NCT03763123)

Mechanisms of Action: VEGF Inhibitor

Novel Mechanism: No

Modality: Antibody

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Jiangsu Simcere
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sevacizumab

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 3: Fallopian Tube Cancer|Ovarian Cancer|Peritoneal Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
CTR20210585	P3	Not yet recruiting	Peritoneal Cancer\|Fallopian Tube Cancer\|Ovarian Cancer	None

Recent News Events

Date	Type	Title
05/15/2024	PubMed	Posterior vitreous attachment as a risk factor for endophthalmitis following intravitreal antivascular endothelial growth factor injection.
05/15/2024	PubMed	Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
04/29/2024	PubMed	A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu-positive metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105).

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions